IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Sorrento Therapeutics Inc (SRNE)

CUSIP: 83587F202 | NYSE | Healthcare · Biotechnology | Micro Cap | 629 institutional holders

Quarters

Q3 2026Q2 2026Q1 2026Q4 2025Q3 2025
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2026

Oakworth Capital, Inc.350
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Oakworth Capital, Inc.
350$00.0%ETFLowBirmingham, AL2026-10-26